109 Participants Needed

I-CARE Program for Mental Health Disorders

(I-CARE Trial)

Recruiting at 1 trial location
SC
Overseen ByStephanie C. Acquilano, MA
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Dartmouth-Hitchcock Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to test the I-CARE program in children who are in a medical hospital awaiting inpatient mental health treatment. The main questions it aims to answer are: * Can the I-CARE program be used at the medical hospitals and do the patients and hospital staff like the program? * Does the I-CARE program lower patients' emotional distress, thoughts about suicide or suicide attempts? Patients will complete as many of the 7 I-CARE videos as possible during their stay at the medical hospital and fill out online surveys. There are workbook activities that go with each I-CARE video. A hospital staff member will help the patient do the videos and workbook activities.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the I-CARE treatment for mental health disorders?

Research shows that programs focusing on patient education and involvement in treatment can lead to positive outcomes, such as reduced symptoms and increased engagement in recovery. Additionally, recovery-oriented models of care have shown significant improvements in social connection, symptoms, and self-belief, suggesting that similar approaches like I-CARE may be effective.12345

Is the I-CARE Program for Mental Health Disorders safe for humans?

The available research on the ICare program, which involves internet-based interventions for mental health, does not specifically address safety concerns, but these types of interventions are generally considered safe as they are non-invasive and focus on self-help and education.678910

How is the I-CARE treatment different from other treatments for mental health disorders?

The I-CARE treatment is unique because it focuses on internet-based interventions, which can improve access to mental health care by providing online support for conditions like depression, anxiety, substance abuse, and eating disorders. This approach can help bridge the gap for those waiting for face-to-face treatment and address access issues in different settings.3681112

Research Team

JK

JoAnna K Leyenaar, MD, PhD, MPH

Principal Investigator

Dartmouth Health

Eligibility Criteria

This trial is for English-speaking children aged 12-17 who are in a medical hospital due to suicidal thoughts or attempts, waiting for mental health treatment. They must be supervised by a safety attendant and can start the day after they're medically cleared.

Inclusion Criteria

Experiencing psychiatric boarding while awaiting transfer for inpatient psychiatric care
I am eligible the day after being admitted or cleared by a hospital.
Supervised one-on-one by a safety attendant
See 1 more

Exclusion Criteria

Admission or transfer for psychiatric care anticipated on the first day of potential enrollment
My parent or guardian does not speak English or Spanish fluently.
Cognitive or developmental delays that preclude program participation based on clinical team assessment
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Treatment

Participants engage with the I-CARE program, completing as many of the 7 videos and workbook activities as possible during their hospital stay.

Approximately 72 hours
Continuous engagement during hospital stay

Follow-up

Participants are monitored for changes in emotional distress and suicidal ideation post-discharge.

6 months
Follow-up assessments at 30 days, 3 months, and 6 months post-discharge

Treatment Details

Interventions

  • Improving Care, Accelerating Recovery & Education (ICARE)
Trial Overview The I-CARE program, which includes videos and workbook activities aimed at reducing emotional distress and suicide risk among hospitalized youth awaiting psychiatric care, is being tested for its effectiveness and acceptability.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: I-CAREExperimental Treatment1 Intervention
I-CARE (Improving Care, Accelerating Recovery \& Education) is a quality improvement program designed to deliver evidence-based psychosocial skills to adolescents during mental health boarding. The program consists of 7 web-based animated videos and workbook exercises, facilitated by licensed nursing assistants/behavioral health technicians/safety attendants who provide one-on-one safety supervision during boarding. I-CARE will be offered to all eligible adolescents who are boarding and only those who agree to participate in a program evaluation will be involved in the research component.
Group II: Usual CareActive Control1 Intervention
These hospitals currently offer basic safety supervision and medical monitoring for adolescents during mental health boarding. This is the "usual care" condition.

Improving Care, Accelerating Recovery & Education (ICARE) is already approved in United States for the following indications:

🇺🇸
Approved in United States as I-CARE for:
  • Mental health treatment for children awaiting inpatient care

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dartmouth-Hitchcock Medical Center

Lead Sponsor

Trials
548
Recruited
2,545,000+

University of Vermont

Collaborator

Trials
283
Recruited
3,747,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Dartmouth College

Collaborator

Trials
93
Recruited
1,415,000+

Children's Hospital of Philadelphia

Collaborator

Trials
749
Recruited
11,400,000+

University of Vermont Medical Center

Collaborator

Trials
46
Recruited
25,900+

Findings from Research

A quality improvement project involving 124 psychiatric patients showed that individualized safety plans created during inpatient treatment were well-tailored, scoring an average of 32.85 out of 44 on a customization rubric.
Postdischarge, 96.1% of patients retained their safety plans, and 36.8% reported using them, with 67.9% of those users finding the plans helpful, indicating that these plans can support recovery after hospitalization.
Bridging the Gap Between Individualized Inpatient Safety Planning and Postdischarge Efficacy.Leonard, J., Chiappetta, L., Stark, S., et al.[2023]
The RECOVER model for mental health care is being tested against standard care (TAU) in a study involving 890 patients, focusing on its effectiveness in reducing healthcare costs and improving patient outcomes over 6 and 12 months.
The study will measure key outcomes such as symptom improvement, daily functioning, and quality of life, using rigorous statistical methods to ensure unbiased results, which could demonstrate the cost-effectiveness of the RECOVER model.
Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER).Lambert, M., Karow, A., Gallinat, J., et al.[2023]
The adapted Illness Management and Recovery (IMR) program significantly improved illness-management knowledge, attitudes toward medication, insight, and negative symptoms in 97 individuals with schizophrenia compared to treatment as usual (TAU) during a randomized controlled trial in Taiwan.
This study is the first to evaluate the IMR program in an acute inpatient setting in East Asia, demonstrating its feasibility and potential benefits for preparing individuals for community reintegration after hospitalization.
A randomized controlled trial of an adapted Illness Management and Recovery program for people with schizophrenia awaiting discharge from a psychiatric hospital.Lin, EC., Chan, CH., Shao, WC., et al.[2019]

References

Bridging the Gap Between Individualized Inpatient Safety Planning and Postdischarge Efficacy. [2023]
Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER). [2023]
A randomized controlled trial of an adapted Illness Management and Recovery program for people with schizophrenia awaiting discharge from a psychiatric hospital. [2019]
Care pathways, engagement and outcomes associated with a recovery-oriented intermediate stay mental health program. [2020]
The Illness Management and Recovery program: rationale, development, and preliminary findings. [2018]
Current state of scientific evidence on Internet-based interventions for the treatment of depression, anxiety, eating disorders and substance abuse: an overview of systematic reviews and meta-analyses. [2021]
A one year follow-up of illness management and recovery: participants' accounts of its impact and uniqueness. [2019]
Assessing the costs and cost-effectiveness of ICare internet-based interventions (protocol). [2022]
Improving Physical Health Among People With Serious Mental Illness: The Role of the Specialty Mental Health Sector. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Integrated medical care for patients with serious psychiatric illness: a randomized trial. [2022]
Stakeholder consultation to facilitate implementation of interventions for prevention and promotion in mental health in Europe: introducing the design of the ICare Stakeholder Survey. [2021]
Integrated mental health care: practitioners' perspectives. [2017]